Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#381 of 589

Yigal Nochomovitz

Citigroup · Equity Research Analyst
EstablishedRating since 2017No new ratings since Nov 2025

Analyst rating accuracy & track record

Yigal Nochomovitz is an equity research analyst at Citigroup. Quantellect has scored 58 of their stock calls across 27 companies. Their picks beat their sector 38% of the time over the next 12 months, and their price targets were reached 33% of the time within a year.

Win % vs sector
38%
PT Hit % (12mo)
33%
Avg sector-excess
−9.0%
Scored calls
58
Tickers
27
Tier
Established

Track record

Quantellect has scored 58 of Yigal Nochomovitz's stock calls across 27 companies, dating back to 2017. Their rated stocks beat their own sector 38% of the time over the next 12 months. On a typical call, a Nochomovitz pick returned −9.0% more than its sector over the following year.

Of the scored calls, 57 were bullish (Buy) and 1 were bearish (Sell). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
CRSPCrispr Therapeutics AG
Buy$77.00Nov 2025−40.6%Miss
AVBPArriVent BioPharma, Inc. Common Stock
Buy$31.00Nov 2025−57.8%Hit
BMEABiomea Fusion Inc
Buy$6.00Nov 2025−87.3%Miss
ARDXArdelyx Inc
Buy$11.00Nov 2025−73.8%Miss
RCUSArcus Biosciences Inc
Buy$56.00Oct 2025−36.4%Miss
ACADACADIA Pharmaceuticals Inc
Buy$33.00Oct 2025−29.2%Miss
SMMTSummit Therapeutics PLC
Buy$40.00Oct 2025−39.1%Miss
RCUSArcus Biosciences Inc
Buy$54.00Oct 2025+23.9%Miss
PROKProKidney Corp.
Buy$10.00Sep 2025−44.2%Miss
AVBPArriVent BioPharma, Inc. Common Stock
Buy$33.00Aug 2025+46.6%Hit
ARCTArcturus Therapeutics Holdings Inc
Buy$49.00Aug 2025−88.5%Miss
BMEABiomea Fusion Inc
Buy$7.00Aug 2025−51.5%Miss
ZLABZai Lab Ltd
Buy$69.00Aug 2025−54.0%Miss
ZYMEZymeworks Inc. Common Stock
Buy$22.00Aug 2025+57.1%Hit
LXRXLexicon Pharmaceuticals Inc
Buy$1.90Aug 2025+99.8%Hit
SNDXSyndax Pharmaceuticals Inc
Buy$51.00Aug 2025+27.1%Miss
LENZLENZ Therapeutics Inc
Buy$52.00Aug 2025−106.5%Miss
APLSApellis Pharmaceuticals Inc
Buy$52.00Aug 2025−109.6%Miss
LENZLENZ Therapeutics Inc
Buy$49.00Jul 2025−107.9%Hit
APLSApellis Pharmaceuticals Inc
Buy$46.00Jul 2025−109.4%Miss
BMEABiomea Fusion Inc
Buy$9.00Jul 2025−56.5%Miss
PROKProKidney Corp.
Buy$9.00Jul 2025−85.8%Miss
APLSApellis Pharmaceuticals Inc
Buy$41.00May 2025−97.7%Hit
ARDXArdelyx Inc
Buy$10.00May 2025+88.8%Miss
LENZLENZ Therapeutics Inc
Buy$47.00Mar 2025−61.3%Hit
Prev1
Go to

Yigal Nochomovitz: analyst track record FAQ

Is Yigal Nochomovitz a good stock analyst?

Yes, by track record. Yigal Nochomovitz ranks number 381 of 589 of the analysts Quantellect scores, with an Analyst Score of 23 out of 100. Past results do not guarantee future ones.

What is Yigal Nochomovitz's win rate?

Yigal Nochomovitz's win rate is 38%. Across 58 scored calls, their rated stocks beat their sector 38% of the time over the next 12 months. On a typical call they returned −9.0% more than the sector.

What stocks and sectors does Yigal Nochomovitz cover?

Yigal Nochomovitz covers 27 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Yigal Nochomovitz's price targets accurate?

Yigal Nochomovitz's price targets are reached within 12 months 33% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Yigal Nochomovitz's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Yigal Nochomovitz rank among Wall Street analysts?

Yigal Nochomovitz ranks number 381 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.